普洛药业：子公司头孢地尼胶囊获得药品注册证书

Core Viewpoint - Pro Pharmaceutical announced that its subsidiary, Zhejiang Pro Pharmaceutical Co., Ltd., has received a drug registration certificate for Cefdinir capsules from the National Medical Products Administration [1] Group 1: Product Information - Cefdinir capsules are indicated for infections caused by various bacteria, including Staphylococcus, Streptococcus, Pneumococcus, and others [1]